Executive Summary
On April 13, 2026, Vice Chancellor Bonnie W. David of the Delaware Court of Chancery dismissed three derivative suits against Tesla, Inc. by enforcing a Texas exclusive forum bylaw adopted after the suits were filed, ruling that shareholder approval of the redomestication was sufficient to apply the new bylaw retroactively. Every Delaware-incorporated company under active or anticipated derivative threat now has a confirmed litigation pathway: redomesticate, adopt a forum selection bylaw with shareholder approval, and the derivative exposure moves with it. The board that understands this option before its adversaries file is the board that controls the terrain.
The Signal at a Glance
Delaware Chancery holds that a forum selection bylaw adopted after derivative litigation is filed, but before the cases advance beyond the pleading stage, is enforceable and can dismiss pending suits when shareholders approved it as part of a redomestication.
The Deep Dive
The Signal
Three derivative suits were filed in the Delaware Court of Chancery between May and June 2024, each targeting Tesla board members after the company announced its intent to redomesticate to Texas. The lawsuits arrived after the announcement but before shareholder approval of the move. Within hours of the final filing, shareholders voted to approve the redomestication and the accompanying Texas bylaws, which designated Texas courts as the exclusive forum for derivative actions.
Vice Chancellor David, in an opinion issued April 13, 2026, declined to adopt a per se rule requiring venue to be fixed at the date of filing. She held that the corporate relationship is “by design, flexible and subject to change,” that shareholders hold no “vested right” to litigate in a particular forum, and that the strong case for enforcement was the announcement predating the suits. The court dismissed all three actions, directing plaintiffs to Texas.
The Evidence
Case: In re Tesla, Inc. Derivative Litigation, C.A. No. 2024-0631-BWD (Del. Ch. Apr. 13, 2026). Opinion: courts.delaware.gov. Judicial officer: Vice Chancellor Bonnie W. David.
The court addressed three plaintiff defenses and rejected each. First, it refused to fix venue at the time of filing, noting that other jurisdictions applying Delaware law have enforced post-filing forum bylaws. Second, it held that Delaware General Corporation Law Section 266(e) governs the substantive law applicable to pre-redomestication events, not the forum where those events must be litigated. Third, it rejected the argument that Texas law offers fewer stockholder protections, stating it was “loath to second-guess Tesla stockholders’ chosen forum.”
The opinion also confirmed that challenges to the underlying redomestication transaction cannot be used to escape the forum clause. A plaintiff who does not allege that shareholders were misled specifically about the forum bylaw itself cannot invoke that misrepresentation as a shield against transfer.
The Strategic Implication
Defensive Risk. Lead independent directors and general counsel at Delaware corporations currently facing derivative suits, or whose Caremark exposure has grown under the 2022 officer-oversight expansion, face a narrowing window. The Tesla opinion confirms the pathway is available, but the enforcement logic depends heavily on announcement sequence: the bylaw was publicly announced before the suits were filed, and it became effective before the cases advanced past the pleading stage. Boards that wait until after a derivative suit has materially progressed cannot replicate Tesla’s outcome. The responsible defensive move is to commission a redomestication feasibility analysis before the next annual meeting or the next significant derivative filing, whichever comes first.
Offensive Advantage. Boards in industries with elevated Caremark or AI-governance derivative risk (technology, financial services, healthcare) now have a confirmed forum-management tool available before litigation materializes. A board that adopts a Texas or Nevada exclusive forum bylaw with proper shareholder approval and advance public disclosure is not merely managing litigation costs. It is relocating the accountability conversation to a jurisdiction whose courts have not yet developed Delaware’s decades of plaintiff-favorable derivative doctrine. General counsel who build this option into the next governance review cycle, before an activist files, gain a structural advantage that cannot be acquired after the fact.
The board that governs litigation exposure before the derivative petition arrives is the board that avoids the most expensive governance lessons. The Touch Stone Publishers AI Governance Chairman’s Briefing maps the overlap between emerging Caremark doctrine, forum strategy, and board-level oversight obligations for technology decisions. The board that requires that analysis is the board that avoids the exposure it describes.